Sumitomo Mitsui Trust Group Inc. Has $712.66 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sumitomo Mitsui Trust Group Inc. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,450,638 shares of the medical equipment provider’s stock after purchasing an additional 48,658 shares during the quarter. Intuitive Surgical accounts for 0.5% of Sumitomo Mitsui Trust Group Inc.’s holdings, making the stock its 29th biggest position. Sumitomo Mitsui Trust Group Inc.’s holdings in Intuitive Surgical were worth $712,655,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ISRG. Hazlett Burt & Watson Inc. raised its position in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after buying an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. lifted its position in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC boosted its holdings in Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC lifted its position in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares in the last quarter. Finally, Falcon Wealth Planning grew its holdings in shares of Intuitive Surgical by 0.4% in the 3rd quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock valued at $2,797,000 after acquiring an additional 23 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company’s stock, valued at $402,519.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 68,006 shares of company stock worth $33,727,766 over the last three months. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Morgan Stanley lifted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Trading Down 0.1 %

Shares of ISRG stock opened at $535.75 on Tuesday. The stock has a 50 day simple moving average of $494.78 and a 200 day simple moving average of $453.94. Intuitive Surgical, Inc. has a 1 year low of $281.12 and a 1 year high of $542.59. The stock has a market cap of $190.82 billion, a P/E ratio of 86.13, a price-to-earnings-growth ratio of 5.27 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.